Leif Stenke
Uppsala University(SE)Karolinska University Hospital(SE)Karolinska Institutet(SE)Svenska Örtmedicinska Institute(SE)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Eosinophilic Disorders and Syndromes, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia(2013)626 cited
- → Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial(2018)593 cited
- → Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial(2011)512 cited
- → BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia(2014)364 cited
- → Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy(2009)318 cited
- → Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia